Claiton Viegas Brenol Selected Research

Claiton Viegas Brenol Research Topics

Disease

28	Rheumatoid Arthritis 12/2021 - 05/2008
6	Rheumatic Diseases (Rheumatism) 04/2019 - 05/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2012
3	Infections 08/2019 - 08/2017
3	Tuberculosis (Tuberculoses) 08/2017 - 05/2015
2	Synovitis 12/2021 - 01/2015
2	Dyslipidemias (Dyslipidemia) 01/2021 - 09/2007
2	Neoplasms (Cancer) 05/2015 - 08/2012
1	Tenosynovitis 12/2021
1	Fibromyalgia (Fibrositis) 07/2020
1	Pain (Aches) 01/2020
1	Psoriatic Arthritis 03/2019
1	Chronic Disease (Chronic Diseases) 03/2018
1	Fatigue 03/2018
1	Latent Tuberculosis 08/2017
1	Ankylosing Spondylitis 05/2015
1	Bacterial Infections (Bacterial Infection) 05/2015
1	Necrosis 05/2015
1	Hematologic Neoplasms (Hematological Malignancy) 05/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Tetanus 02/2013
1	Human Influenza (Influenza) 02/2013
1	Chickenpox 02/2013
1	Hepatitis A (Hepatitis, Infectious) 02/2013
1	Hereditary Complement Deficiency Diseases 02/2013
1	Osteoporosis 08/2012
1	Diabetes Mellitus 08/2012
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2012
1	Atherosclerosis 08/2012
1	Hypertension (High Blood Pressure) 08/2012
1	Systemic Scleroderma (Systemic Sclerosis) 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2012
1	Atopic Dermatitis (Atopic Eczema) 01/2012
1	Arthritis (Polyarthritis) 05/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2008
1	Insulin Resistance 09/2007

Drug/Important Bio-Agent (IBA)

8	Antirheumatic Agents (DMARD)IBA 12/2021 - 02/2013
6	Biological ProductsIBA 06/2021 - 05/2015
6	Pharmaceutical PreparationsIBA 01/2019 - 04/2013
3	ametantrone (HAQ)IBA 01/2020 - 05/2011
3	Tumor Necrosis Factor InhibitorsIBA 04/2019 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 01/2017
3	Rituximab (Mabthera)FDA Link 09/2017 - 02/2013
3	HLA-G Antigens (HLA G)IBA 01/2015 - 05/2008
2	GlucocorticoidsIBA 01/2021 - 05/2011
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 08/2012
2	C-Reactive ProteinIBA 03/2018 - 01/2015
2	VaccinesIBA 05/2015 - 02/2013
1	Janus Kinase InhibitorsIBA 11/2021
1	N-phthaloylglutamic acidIBA 01/2020
1	milk-derived factorIBA 03/2018
1	Complement System Proteins (Complement)IBA 09/2017
1	Abatacept (Orencia)FDA Link 01/2017
1	Etanercept (Enbrel)FDA Link 01/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Hormones (Hormone)IBA 07/2015
1	Leukocyte Immunoglobulin-like Receptor B1IBA 01/2015
1	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2013
1	AntibodiesIBA 02/2013
1	Immunoglobulins (Immunoglobulin)IBA 02/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2013
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 02/2013
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 02/2013
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2013
1	BCG Vaccine FDA Link 02/2013
1	LDL CholesterolIBA 08/2012
1	Angiotensin Receptor AntagonistsIBA 08/2012
1	Dietary CalciumIBA 08/2012
1	CalciumIBA 08/2012
1	Vitamin D FDA LinkGeneric 08/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2012
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2012
1	Rheumatoid FactorIBA 05/2011
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 05/2011
1	cyclic citrullinated peptideIBA 05/2011
1	Anti-Citrullinated Protein AntibodiesIBA 05/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2009
1	CytokinesIBA 09/2007

Therapy/Procedure

7	Therapeutics 12/2021 - 08/2012
3	Biological Therapy 01/2017 - 05/2015